Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

FDA approves first treatment for inherited rare disease
FDA approves first treatment for inherited rare disease
Today, the U.
Allergan builds case for migraine drug ubrogepant as FDA verdict nears
Allergan builds case for migraine drug ubrogepant as FDA verdict nears
Allergan’s ubrogepant could become the first oral drug in the new CGRP inhibitor class if it is approved by the FDA in December, but is still facing a challenge in the market.
AbbVie signs potential $2.4bn cancer immunotherapy deal with Harpoon
AbbVie signs potential $2.4bn cancer immunotherapy deal with Harpoon
AbbVie has signed a deal worth up to $2.
$74bn BMS/Celgene merger finally cleared by competition regulators
$74bn BMS/Celgene merger finally cleared by competition regulators
Bristol-Myers Squibb and Celgene’s merger looks set to close tomorrow after US competition regulators finally gave the $74 billion deal the go-ahead.
Successful study of Swedish vaccine candidate against diarrhea
Successful study of Swedish vaccine candidate against diarrhea
University of Gothenburg researchers have reported the first successful results of an oral, inactivated vaccine candidate ETVAX against enterotoxigenic E.
FDA approves first contact lens to slow childhood nearsightedness
FDA approves first contact lens to slow childhood nearsightedness
The FDA has approved its first contact lens designed to effectively slow the progression of nearsightedness in children, starting in ages 8 to 12.
Alnylam's rare genetic disorder drug priced at $575,000 per year
Alnylam's rare genetic disorder drug priced at $575,000 per year
(Reuters) - Alnylam Pharmaceuticals Inc priced its gene silencing drug to treat patients with a rare genetic disorder that can cause severe pain at $575,000 per year after receiving an early U...
Merck and Bayer's heart drug meets main goal of late-stage study
Merck and Bayer's heart drug meets main goal of late-stage study
(Reuters) - Merck & Co Inc said on Monday an experimental treatment being developed with Bayer AG for patients with worsening chronic heart failure met the main goal of a late-stage study.
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001® for Severe Hemoglobinopathies
ZUG, Switzerland and CAMBRIDGE, Mass.
Milestone reached in new leukemia drug
Milestone reached in new leukemia drug
Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute (DFCI), have developed a new therapy that extended the survival of mice with acu...
Ketamine could help men suffering from alcohol use disorder
Ketamine could help men suffering from alcohol use disorder
Research from Florida State University is giving physicians a better understanding of ketamine, a potentially useful tool in treating depression that still has unanswered questions.
Janssen says the design will “reimagine” drug development and is the “next evolution” of clinical trials
Janssen says the design will “reimagine” drug development and is the “next evolution” of clinical trials
The study promises to improve clinical research with an innovative and patient-friendly approach.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand